ALCON AG's ticker is ALC and the CUSIP is H01301128. A total of 560 filers reported holding ALCON AG in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $119,772,491 | +2.1% | 1,613,951 | +11.4% | 0.20% | +12.9% |
Q2 2023 | $117,361,293 | +22.7% | 1,448,266 | +6.9% | 0.18% | +20.3% |
Q1 2023 | $95,615,873 | -62.3% | 1,355,399 | -68.9% | 0.15% | -66.1% |
Q3 2022 | $253,717,000 | -13.6% | 4,360,350 | +3.7% | 0.44% | -7.2% |
Q2 2022 | $293,733,000 | -44.8% | 4,202,786 | -20.8% | 0.47% | -34.1% |
Q1 2022 | $532,015,000 | +14.6% | 5,308,108 | -0.4% | 0.71% | +14.1% |
Q4 2021 | $464,145,000 | +5.1% | 5,327,656 | -2.9% | 0.62% | -0.2% |
Q3 2021 | $441,727,000 | +13.6% | 5,489,335 | -0.8% | 0.63% | +15.7% |
Q2 2021 | $388,683,000 | +9.3% | 5,532,070 | +9.2% | 0.54% | -0.2% |
Q1 2021 | $355,546,000 | +43.6% | 5,066,203 | +35.0% | 0.54% | +1.3% |
Q4 2020 | $247,551,000 | +278.6% | 3,751,916 | +226.8% | 0.54% | +230.2% |
Q3 2020 | $65,385,000 | +8.6% | 1,148,111 | +9.3% | 0.16% | +0.6% |
Q2 2020 | $60,226,000 | +25.7% | 1,050,699 | +11.5% | 0.16% | +4.5% |
Q1 2020 | $47,905,000 | -9.9% | 942,628 | +0.3% | 0.15% | +18.5% |
Q4 2019 | $53,155,000 | -67.5% | 939,634 | -66.5% | 0.13% | -69.7% |
Q3 2019 | $163,367,000 | – | 2,802,666 | – | 0.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rudius Management LP | 1,643,756 | $143,204,000 | 55.08% |
Exane Asset Management | 1,082,835 | $95,769,633,000 | 24.99% |
Martin Investment Management, LLC | 339,607 | $29,587,000 | 7.33% |
ABEILLE ASSET MANAGEMENT SA | 290,564 | $25,730,000 | 5.96% |
Ako Capital | 5,321,077 | $467,372,000 | 4.55% |
SIRIOS CAPITAL MANAGEMENT L P | 427,666 | $37,258,000 | 4.27% |
Banque Cantonale Vaudoise | 1,120,603 | $99,296,000 | 3.87% |
HARDING LOEVNER LP | 10,969,684 | $955,696,000 | 3.66% |
BRIDGER MANAGEMENT, LLC | 274,215 | $23,890,000 | 3.09% |
LATHROP INVESTMENT MANAGEMENT CORP | 169,980 | $14,809,000 | 2.91% |